Perth based Pharmaust has received a $250k Federal grant to conduct a research program into a little known illness known as Leishmaniasis disease. They will work in partnership with a Swiss not for profit who will retain rights to any drugs produced for humans with Pharmaust retaining the rights to any drugs developed that cure Leishmaniasis in animals.
17/06/2016 - 11:54
Pharmaust gets $250k grant to fight “parasitic” disease
By Matt Birney
17/06/2016 - 11:54
Related Data & Insights
-
-
Rank Company Revenue 128th PharmAust $3.8m 137th Adisyn $2.9m 138th rent.com.au $2.8m 141st Douugh $2.5m 142nd Hazer Group $2.4m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
24 Apr 2024
Board Moves, April 24 2024
23 Apr 2024
PharmAust CEO resigns
05 Feb 2024
Board Moves February 5, 2024
28 Aug 2023
Board Moves August 28, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX